Table 4.
Highest level of respiratory support and adjunctive therapies among neonates with composite respiratory morbidity
| 34 | 35 | 36 | LPI | 37 | 38 | 39 | 40 | 41 | TI | |
|---|---|---|---|---|---|---|---|---|---|---|
| |
n = 38 |
n = 38 |
n = 29 |
n = 105 |
n = 32 |
n = 28 |
n = 19 |
n = 28 |
n = 14 |
n = 121 |
| Nasal oxygen** |
0 (0.0) |
1 (2.6) |
2 (6.9) |
3 (2.9) |
5 (15.6) |
2 (7.1) |
3 (15.8) |
5 (17.9) |
3 (21.4) |
18 (14.9) |
| N-CPAP*** |
26 (68.4) |
26 (68.4) |
16 (55.2) |
68 (64.8) |
13 (40.6) |
11 (39.3) |
6 (31.6) |
4 (14.3) |
5 (35.7) |
39 (32.2) |
| MV |
7 (18.4) |
4 (10.5) |
2 (6.9) |
13 (12.4) |
5 (15.6) |
2 (7.1) |
2 (10.5) |
5 (17.9) |
2 (14.3) |
16 (13.2) |
| Surfactant* |
6 (15.8) |
7 (18.4) |
4 (13.8) |
17 (16.2) |
5 (15.6) |
0 (0.0) |
0 (0.0) |
3 (10.7) |
0 (0.0) |
8 (6.6) |
| INO |
0 (0.0) |
2 (5.3) |
2 (6.9) |
4 (3.8) |
3 (9.4) |
0 (0.0) |
0 (0.0) |
2 (7.1) |
0 (0.0) |
5 (4.1) |
| Pleural drainage |
6 (15.8) |
1 (2.6) |
1 (3.5) |
8 (7.6) |
5 (15.6) |
1 (3.6) |
0 (0.0) |
1 (3.6) |
1(7.1) |
8 (6.6) |
| Data are expressed as absolute numbers and proportions (%) of observed data in each category. All tests refer to comparisons between late preterm infants (LPI) and term infants (TI). | ||||||||||
***P < .001, using χ2or Fisher test as appropriate.
**P < .01, using χ2or Fisher test as appropriate.
*P < .05, using χ2or Fisher test as appropriate.